跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tonavir - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tonavir
Approved
STANDARD
Tonavir
Hetero Labs Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1bc4237651429087
Company
Hetero Labs Limited
Type
Standard
Approval Details
Approval Id
1bc4237651429087
Drug Approval Philippines Name
Tonavir
Product Name
Tonavir
Registration Number
DR-XY48145
Brand Name
Tonavir
Generic Name
Ritonavir
Dosage Form
Film Coated Tablet
Dosage Strength
100 mg
Manufacturer
Hetero Labs Limited
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Company Detail Path
/organization/hetero-labs-limited
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
29 June 2022
Expiry Date
29 June 2027
Pharmacologic Category
Antiretroviral (Protease Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1bc4237651429087
Type
Standard
Back to Philippines FDA Approvals